bruceine d has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, R; Han, M; Hu, Y; Wang, L; Yang, Y; Zhu, J | 1 |
| Fan, J; Liu, X; Ren, D; Wang, J; Wu, M; Yang, G; Zhang, H | 1 |
| Huang, Y; Lan, L; Lin, N; Tan, B; Wang, F; Yan, W; Ye, L; Zhang, B | 1 |
3 other study(ies) available for bruceine d and Lung Neoplasms
| Article | Year |
|---|---|
Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.
Topics: Afatinib; Cell Line, Tumor; Cell Proliferation; DNA Damage; ErbB Receptors; Female; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2023 |
Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Quassins; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Brucea; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drugs, Chinese Herbal; Humans; Lung Neoplasms; MAP Kinase Signaling System; Phosphorylation; Quassins | 2019 |